Danforth Advisors, LLC, announces the acquisition of Advyzom, LLC, a leading regulatory affairs consultancy, creating a single, comprehensive resource for life science companies to access the expertise required on the path to proof-of-concept, regulatory approval, and market entry. Danforth’s clinical and regulatory bench now spans experts across preclinical and medical advisory, clinical development operations, regulatory strategy, FDA liaisons and submissions, medical writing, and clinical and CMC outsourcing. Founded in 2011, Advyzom comprises approximately 30 specialists with backgrounds in biotechnology and big pharma, providing expertise in global regulatory strategy, FDA relationships as US agents, document publishing, regulatory submissions, and medical writing.
Read the full article: Danforth Advisors Acquires Advyzom, Establishing Complete Range of Clinical and Regulatory Services for Life Science Companies //
Source: https://www.globenewswire.com/news-release/2024/09/10/2943601/0/en/Danforth-Advisors-Acquires-Advyzom-Establishing-Complete-Range-of-Clinical-and-Regulatory-Services-for-Life-Science-Companies.html